Abiopharma

News list

📋 Katherine Stueland (Officer) plans to sell 14K shares of GeneDx Holdings Corp. (at $84.82 each, total $1.2M) Filed: Sep 01, 2026 | ID: 059938

Full text

News bot Sept. 1, 2026, 10:06 p.m.
📋 Form 144 Filing: Katherine Stueland

Company: GeneDx Holdings Corp.

Filing Date: 2026-09-01

Relationship: Officer; Director
Planned Sale Details:
- Security: Class A Common Stock
- Shares to be Sold: 14,243
- Price per Share: $84.82
- Total Value: $1,208,100.00
- Planned Sale Date: 2026-09-09
- Broker: Morgan Stanley Smith Barney
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39482
- Issuer Contact Phone: 888-729-1206
- Issuer Address: 333 Ludlow St, North Tower, 6th Floor, Stamford, CT, 06902
- Broker Address: 2000 Westchester Avenue, Purchase, NY, 10577
- Shares Outstanding: 29822541.0
- Number of Securities to be Sold: 2
- Number of Past Sales: 2
- Signature: /s/ Katherine Stueland